NDC 68180-348 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68180-348
- Package NDCs from labels
- 68180-348-01, 68180-348-02
- Manufacturer
- Lupin Pharmaceuticals, Inc. | LUPIN LIMITED
- Effective date
- 2018-09-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2018-09-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68180-348-01 | Gabapentin | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 7 | |
| 68180-348-02 | Gabapentin | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 0eb27e64-1488-4083-82c7-cebb8c0605de | 2023-12-20 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | ecb798a0-377d-4712-bb82-ec9d7116962f | 2023-12-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 40bb60c0-a2f3-4e7f-b13c-028c906c4852 | 2023-11-01 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 9c96b488-19bd-431e-af9a-b313ffd9eaae | 2023-10-01 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Asclemed USA, Inc. | 5fb79774-c2d4-47ba-9a16-eb367d0fdcff | 2023-09-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | af62bb7e-162e-4e2a-8eb0-d50f66678707 | 2023-09-22 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 77d1d90d-e124-4db7-b811-754d535e579c | 2023-09-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 22f2294f-352a-4515-87c8-a6ae46e61322 | 2023-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Exelan Pharmaceuticals Inc. | 323dad14-ded9-4432-a265-c957e46cc6db | 2023-03-23 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 35004f84-90ae-45f0-a2ba-653dec507229 | 2023-03-01 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cipla USA Inc. | 7c3ac86f-b8f7-42bf-942a-db854d946e54 | 2023-01-20 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | f7a943ec-9a13-45ba-9bc5-18162b86b921 | 2023-01-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 20e48004-d8b6-40fd-929b-b95087b4d85d | 2022-11-28 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | c7cb37f9-e1df-4e2a-bde5-9bfa0e040d7a | 2022-11-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 88ac51c4-5fa9-4c35-9c63-f26bcb101d4b | 2022-10-18 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | e89a7ff2-bd82-4fde-b2b7-3b9d0edf6fc8 | 2022-10-12 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | 9d544944-ea95-42e1-8c65-9e442437f0ee | 2022-10-10 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | f651a143-3f88-49c9-b5c4-c9af55aea76a | 2022-10-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 176c5b60-93c2-4574-8b51-c15180912aaa | 2022-08-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Neurontin | GABAPENTIN | Parke-Davis Div of Pfizer Inc | ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388 | 2022-07-12 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.